Arnold Conforti, MD
Surgical Oncology · Macon, GANPI 1215932041
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,655 of the $8,513 with a category attached, or 89.9%. It is spread thinly across 43 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,869 and has fallen 84.6% since, to $288 in 2025.
Across 164 payments — averaging $51.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Medical Device Business Services, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$656
- Merck$612
- Endomagnetics Ltd$558
- Johnson & Johnson$367
- plus $3K from 37 others
What the payments were for
- Travel & lodging$85710%
- Food & beverage$7,65590%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$2,806
- CYTAL$1,031
- ATTUNE$963
- INTEGRA DERMAL REGENERATION TEMPLATE$935
- PRIMATRIX$935
- Magseed$512
- Magtrace$512
- LIBTAYO$360
- Axonics r-SNM System$277
- KEYTRUDA$249
- ON-Q* PUMP AND ACCESSORIES$247
- ALIYA SYSTEM$146
- TISSEEL$132
- EVENITY$125
- Prolia$123
- FLOSEAL$120
- PreciseTumor$119
- SOMATULINE DEPOT$118
- Localizer$105
- TRIDENT SPECIMEN RADIOGRAPHY SYSTEM$105
How this compares
$8,513 in reported general payments places this provider in the 80th percentile of 43 surgical oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 76 | $292 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Macon
- Paul DaleMacon$3K
- Eddie AbdallaAtlanta$34K
- Atuhani BurnettAtlanta$23K
- Anita JohnsonWoodstock$18K
- Danny YakoubAugusta$17K
- Nicole KounalakisAtlanta$14K
- Sartaj SangheraMarietta$10K
- Barry RosemanAtlanta$10K
- James GarberSavannah$7K
- James GriffinAthens$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.